X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (10) 10
hematology (9) 9
human necessities (8) 8
hygiene (8) 8
medical or veterinary science (8) 8
oncology (8) 8
preparations for medical, dental, or toilet purposes (8) 8
prognosis (8) 8
acute myeloid leukemia (7) 7
hemic and lymphatic diseases (7) 7
aged (6) 6
leukemia (6) 6
male (6) 6
adult (5) 5
aml (5) 5
female (5) 5
life sciences (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
acute promyelocytic leukemia (4) 4
animals (4) 4
cell biology (4) 4
chemotherapy (4) 4
mice (4) 4
middle aged (4) 4
patients (4) 4
relapse (4) 4
signal transduction (4) 4
abridged index medicus (3) 3
acute myeloid-leukemia (3) 3
cancer (3) 3
chemistry (3) 3
diagnosis (3) 3
differentiation (3) 3
embryonic structures (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - metabolism (3) 3
leukemia, myeloid, acute - therapy (3) 3
medicine, research & experimental (3) 3
metallurgy (3) 3
myeloid leukemia (3) 3
older patients (3) 3
organic chemistry (3) 3
peptides (3) 3
research article (3) 3
specific therapeutic activity of chemical compounds ormedicinal preparations (3) 3
stem cells (3) 3
stem-cells (3) 3
trial (3) 3
young adult (3) 3
acute myelogenous leukemia (2) 2
adult patients (2) 2
analysis (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
aplasia (2) 2
apoptosis - drug effects (2) 2
biology (2) 2
care and treatment (2) 2
chloroma (2) 2
clinical case report (2) 2
cohort studies (2) 2
cytarabine (2) 2
cytokines (2) 2
drug resistance, neoplasm (2) 2
elderly (2) 2
expression (2) 2
fluids and secretions (2) 2
france (2) 2
gene expression profiling (2) 2
hematopoietic stem cells (2) 2
hemic and immune systems (2) 2
immunology (2) 2
immunotherapy (2) 2
in-vivo (2) 2
infections (2) 2
infectious diseases (2) 2
inflammation (2) 2
initiating cells (2) 2
iron (2) 2
kaplan-meier estimate (2) 2
leukemia, myeloid, acute - mortality (2) 2
leukemia, myeloid, acute - pathology (2) 2
leukemic stem cells (2) 2
ligands (2) 2
medicine, general & internal (2) 2
melanoma (2) 2
metastases (2) 2
mice, nude (2) 2
microbiology (2) 2
minimal residual disease (2) 2
multidisciplinary sciences (2) 2
mutations (2) 2
neoplasms (2) 2
nivolumab (2) 2
oxidative stress (2) 2
pembrolizumab (2) 2
pharmacology & pharmacy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Reports, ISSN 2211-1247, 06/2015, Volume 11, Issue 9, pp. 1446 - 1457
Journal Article
Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 4, pp. 398 - 407
Journal Article
Kidney International, ISSN 0085-2538, 12/2012, Volume 82, Issue 12, pp. 1284 - 1296
IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, has significant morbidity and mortality as 20–40% of patients progress to... 
IgA deposition | IgA | IgA nephropathy | KIDNEY-DISEASE | POLYMERIC IGA1 | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | FACTOR-KAPPA-B | ABERRANT GLYCOSYLATION | PREDICTING PROGRESSION | RESONANCE MASS-SPECTROMETRY | TRANSFERRIN RECEPTOR | HINGE REGION | GALACTOSE-DEFICIENT IGA1 | UROLOGY & NEPHROLOGY | Blood Pressure | Antigen-Antibody Complex | Phosphorylation | Cell Proliferation | TOR Serine-Threonine Kinases - metabolism | Calcium - metabolism | Humans | Middle Aged | Glomerulonephritis, IGA - immunology | Podocytes - enzymology | Male | Extracellular Signal-Regulated MAP Kinases - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Antigens, CD - metabolism | Mesangial Cells - drug effects | Glomerulonephritis, IGA - enzymology | Young Adult | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Renin-Angiotensin System | Time Factors | Inflammation Mediators - metabolism | Mesangial Cells - enzymology | Adult | Female | Proto-Oncogene Proteins c-akt - metabolism | Interleukin-6 - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Glomerulonephritis, IGA - pathology | Glomerulonephritis, IGA - physiopathology | Immunoglobulin A - metabolism | Angiotensin II - metabolism | Proteinuria - immunology | Mesangial Cells - immunology | Cells, Cultured | Podocytes - pathology | Receptors, Transferrin - metabolism | Proteinuria - enzymology | MAP Kinase Signaling System - drug effects | Podocytes - drug effects | Biopsy | Podocytes - immunology | Cell Communication - drug effects | Mesangial Cells - pathology | Aged | Enzyme Activation | Glomerulonephritis | End-stage renal disease | Renal function | Cytokines | Immunoglobulin G | Mortality | Extracellular signal-regulated kinase | MAP kinase | Inflammation | Morbidity | Signal transduction | Molecular modelling | Mesangial cells | Blood pressure | Antigen-antibody complexes | Mesangium | Proteinuria
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2019, Volume 102, Issue 2, pp. 131 - 142
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 3/2017, Volume 96, Issue 3, pp. 363 - 371
Journal Article
by Pertesi, M and Vallee, M and Wei, XM and Revuelta, MV and Galia, P and Demangel, D and Oliver, J and Foll, M and Chen, S and Perrial, E and Garderet, L and Corre, J and Leleu, X and Boyle, EM and Decaux, O and Rodon, P and Kolb, B and Slama, B and Mineur, P and Voog, E and Le Bris, C and Fontan, J and Maigre, M and Beaumont, M and Azais, I and Sobol, H and Vignon, M and Royer, B and Perrot, A and Fuzibet, JG and Dorvaux, V and Anglaret, B and Cony-Makhoul, P and Berthou, C and Desquesnes, F and Pegourie, B and Leyvraz, S and Mosser, L and Frenkiel, N and Augeul-Meunier, K and Leduc, I and Leyronnas, C and Voillat, L and Casassus, P and Mathiot, C and Cheron, N and Paubelle, E and Moreau, P and Bignon, YJ and Joly, B and Bourquard, P and Caillot, D and Naman, H and Rigaudeau, S and Marit, G and Macro, M and Lambrecht, I and Cliquennois, M and Vincent, L and Helias, P and Avet-Loiseau, H and Moreno, V and Reis, RM and Varkonyi, J and Kruszewski, M and Vangsted, AJ and Jurczyszyn, A and Zaucha, JM and Sainz, J and Krawczyk-Kulis, M and Watek, M and Pelosini, M and Iskierka-Jazdzewska, E and Grzasko, N and Martinez-Lopez, J and Jerez, A and Campa, D and Buda, G and Lesueur, F and Dudzinski, M and Garcia-Sanz, R and Nagler, A and Rymko, M and Jamroziak, K and Butrym, A and Canzian, F and Obazee, O and Nilsson, B and Klein, RJ and Lipkin, SM and McKay, JD and Dumontet, C and Division of Hematology and Transfusion Medicine and Lund University and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Hematogenomics and Lunds universitet and Avdelningen för hematologi och transfusionsmedicin
LEUKEMIA, ISSN 0887-6924, 09/2019, Volume 33, Issue 9, pp. 2324 - 2330
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4003 - 4003
Abstract Introduction: Despite recent improvements in the treatment of adult acute myeloid leukemia (AML), many patients still fail to achieve complete... 
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 570
Although the outcome in younger adults with acute myeloid leukemia (AML) has improved, the benefit associated with standard intensive chemotherapy in older... 
AML | INTENSIVE CHEMOTHERAPY | elderly | ADULTS | OLDER | TANDEM DUPLICATION | prognosis | STEM | acute myeloid leukemia | ONCOLOGY | CLONAL HEMATOPOIESIS | minimal residual disease | MUTATIONS | molecular markers | AGE 70 YEARS
Journal Article